ARMP
Armata Pharmaceuticals Inc

7,984
Loading...
Loading...
News
all
press releases
Is Arbutus Biopharma (ABUS) Stock Outpacing Its Medical Peers This Year?
Here is how Arbutus Biopharma (ABUS) and Armata Pharmaceuticals, Inc. (ARMP) have performed compared to their sector so far this year.
Zacks·11d ago
News Placeholder
More News
News Placeholder
All You Need to Know About Armata Pharmaceuticals (ARMP) Rating Upgrade to Buy
Armata Pharmaceuticals (ARMP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks·28d ago
News Placeholder
Is Armata Pharmaceuticals (ARMP) Outperforming Other Medical Stocks This Year?
Here is how Armata Pharmaceuticals, Inc. (ARMP) and Avadel (AVDL) have performed compared to their sector so far this year.
Zacks·28d ago
News Placeholder
Armata Pharmaceuticals, Inc. (ARMP) Reports Q2 Loss, Beats Revenue Estimates
Armata Pharmaceuticals (ARMP) delivered earnings and revenue surprises of +17.95% and +57.17%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
ARMP Soars 72% in a Month Following Infectious Disease Study Success
Zacks·4mo ago
News Placeholder
Armata Pharmaceuticals, Inc. (ARMP) Reports Q1 Loss, Lags Revenue Estimates
Zacks·4mo ago
News Placeholder
ADC Therapeutics SA (ADCT) Reports Q1 Loss, Tops Revenue Estimates
Zacks·4mo ago
News Placeholder
Sangamo Therapeutics (SGMO) Reports Q1 Loss, Misses Revenue Estimates
Zacks·4mo ago

Latest ARMP News

View

Advertisement. Remove ads.

Advertisement. Remove ads.